Your browser doesn't support javascript.
loading
Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An In-Silico Approach.
Jubie, Selvaraj; Durai, Uma; Latha, Subbiah; Ayyamperumal, Selvaraj; Wadhwani, Ashish; Prabha, Thangavelu.
Afiliación
  • Jubie S; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Researchooty, Nilgiris, Ooty-643001, Tamilnadu, India.
  • Durai U; Department of Chemistry, PSG College of Arts & Science, Avinasi Road, Coimbatore- 641 014, Tamilnadu, India.
  • Latha S; Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research, Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamilnadu, India.
  • Ayyamperumal S; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Researchooty, Nilgiris, Ooty-643001, Tamilnadu, India.
  • Wadhwani A; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Researchooty, Nilgiris, Ooty-643001, Tamilnadu, India.
  • Prabha T; Department of Pharmaceutical Chemistry, Nandha College of Pharmacy, Affiliated to The Tamilnadu Dr. MGR. Medical University-Chennai, Erode-638052, Tamilnadu, India.
Curr Drug Res Rev ; 13(1): 73-83, 2021.
Article en En | MEDLINE | ID: mdl-32955008

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bencimidazoles / Neoplasias de la Mama / Inhibidores de Proteínas Quinasas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Curr Drug Res Rev Año: 2021 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bencimidazoles / Neoplasias de la Mama / Inhibidores de Proteínas Quinasas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Curr Drug Res Rev Año: 2021 Tipo del documento: Article País de afiliación: India
...